CELLZOME UK LTD has a total of 24 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Argentina. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are GENE KUTATO KFT N, PIMCO 2664 LTD and IMTM GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Argentina | 2 | |
#4 | China | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Taiwan | 1 | |
#9 | United States | 1 | |
#10 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dyke Hazel | 16 |
#2 | Cramp Sue | 16 |
#3 | Wilson Francis | 14 |
#4 | Price Steve | 10 |
#5 | Reid Alison | 7 |
#6 | Price Steven | 6 |
#7 | Ramsden Nigel | 4 |
#8 | Burckhardt Svenja | 3 |
#9 | Szabo Andras | 3 |
#10 | Sunose Mihiro | 3 |
Publication | Filing date | Title |
---|---|---|
WO2007090854A1 | Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders | |
WO2007090853A1 | Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders | |
EP1925619A1 | Preparation of 4-substituted 2-amino-benzo[4,5]furo[3,2-d]pyrimidine derivatives | |
EP1860109A1 | Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders | |
EP1860108A1 | Enantiomers of Amino Pyrimidine compounds for the treatment of inflammatory disorders | |
EP1829879A1 | Amino pyrimidine compounds for the treatment of inflammatory disorders | |
EP1767537A1 | Pyrimidine compounds for the treatment of inflammatory disorders |